APP
BIIB icon

Avantax Planning Partners’s Biogen BIIB Stock Holding History

Avantax Planning Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-292
Closed -$103K – 381
2018
Q3 		$103K Buy
+292
New +$101K 0.01% 340
2018
Q2 		– Sell
-106
Closed -$28K – 378
2018
Q1 		$28K Buy
+106
New +$32.9K ﹤0.01% 664

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Avantax Planning Partners's BIIB Position: Q4 2018 in Review

Avantax Planning Partners sold out of Biogen (BIIB) in Q4 2018, closing a stake of 292 shares — an estimated $103K sold.

Avantax Planning Partners first reported a position in BIIB in Q1 2018 and held it in 2 quarters. The position peaked at $103K in Q3 2018. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Avantax Planning Partners reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 292 Biogen shares in Q4 2018, an estimated $103K.
  • Avantax Planning Partners first reported a position in Biogen in Q1 2018 and held it in 2 quarters.
  • Avantax Planning Partners's Biogen position peaked at $103K in Q3 2018.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.